PTGS2 and prostate cancer: But the most exciting finding in our study was the reduction in COX2 cell coverage (TLO and non-TLO areas), accompanied by the low number of Treg and the considerable increase in Tbet+ Th1 cells in TLO from unique patients that experienced spontaneous prostate cancer regression.